Consistent decline of acetylcholine in microbiota-gut-brain axis mediates antibiotic-induced anxiety via regulating

Ke Xu1,2, Yi Ren1,2, Shuang Zhao3,4

  • 1Department of Neurology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China.

Molecular Psychiatry
|December 23, 2025
PubMed

Insights

Antibiotic abuse is linked to anxiety. Researchers found reduced acetylcholine and altered gut bacteria in mice and patients, suggesting a potential treatment with acetylcholine derivatives to restore mood.

Area of Science:

  • Neuroscience
  • Microbiology
  • Pharmacology

Background:

  • Antibiotic (AB) overuse is a global concern.
  • Potential links between antibiotic use and mental health disorders are emerging.
  • The gut-brain axis plays a crucial role in regulating mood and behavior.

Purpose of the Study:

  • To investigate the impact of antibiotics on mental health, specifically anxiety.
  • To explore the underlying mechanisms involving gut microbiota, short-chain fatty acids (SCFAs), lipid metabolism, and acetylcholine.
  • To evaluate the therapeutic potential of acetylcholine derivatives in mitigating antibiotic-induced anxiety.

Main Methods:

  • Antibiotic-treated mice models were used to assess behavioral changes, gut microbiota composition, SCFA levels, lipid metabolism, and acetylcholine concentrations.
  • Human studies included antibiotic-treated patients, antibiotic-naïve patients, and healthy controls, analyzing fecal and serum samples for microbial and metabolic profiles, and acetylcholine levels.
  • Co-occurrence analysis identified key microbial-neurotransmitter interactions.
  • Methacholine (an acetylcholine derivative) was administered to mice to assess its therapeutic effects.

Main Results:

  • Antibiotic treatment induced anxiety-like behaviors in mice and patients.
  • Significant alterations in gut microbiota composition (e.g., Firmicutes, Bacteroidota), reduced SCFAs, and disrupted lipid metabolism were observed in both groups.
  • Decreased acetylcholine levels in feces, colon, serum, and hippocampus correlated strongly with anxiety symptoms.
  • The "Bacteroides-acetylcholine" interaction, particularly involving decreased Bacteroides species, was implicated in antibiotic-induced anxiety.
  • Methacholine administration alleviated anxiety-like behaviors and reduced hippocampal microglial activation in mice.

Conclusions:

  • Aggressive antibiotic use negatively impacts mood, potentially leading to anxiety.
  • Reduced acetylcholine levels and gut dysbiosis are key mechanisms underlying antibiotic-induced anxiety.
  • Acetylcholine or its derivatives show promise as a therapeutic strategy to counteract antibiotic-associated mood disturbances.

Related Concept Videos

Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.4K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
457
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K